EyePoint Pharmaceuticals (EYPT) Change in Cash: 2010-2024
Historic Change in Cash for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to -$181.6 million.
- EyePoint Pharmaceuticals' Change in Cash rose 24.04% to -$27.6 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$48.9 million, marking a year-over-year decrease of 591.68%. This contributed to the annual value of -$181.6 million for FY2024, which is 197.81% down from last year.
- Per EyePoint Pharmaceuticals' latest filing, its Change in Cash stood at -$181.6 million for FY2024, which was down 197.81% from $185.6 million recorded in FY2023.
- In the past 5 years, EyePoint Pharmaceuticals' Change in Cash registered a high of $185.6 million during FY2023, and its lowest value of -$181.6 million during FY2024.
- Moreover, its 3-year median value for Change in Cash was -$83.0 million (2022), whereas its average is -$26.3 million.
- As far as peak fluctuations go, EyePoint Pharmaceuticals' Change in Cash spiked by 489.05% in 2021, and later plummeted by 197.81% in 2024.
- Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Change in Cash stood at $22.7 million in 2020, then surged by 489.05% to $133.7 million in 2021, then plummeted by 162.06% to -$83.0 million in 2022, then skyrocketed by 323.76% to $185.6 million in 2023, then tumbled by 197.81% to -$181.6 million in 2024.